Skip to main content
Top

Current Oncology Reports

Issue 1/2005

Content (16 Articles)

Clinical Trials Report

Two regimens of docetaxel for metastatic breast cancer

Andrew D. Seidman, Larry Norton

Clinical Trials Report

Comparison of paclitaxel regimens

Andrew D. Seidman, Larry Norton

Clinical Trials Report

Neoadjuvant weekly paclitaxel followed by FAC

Andrew D. Seidman, Larry Norton

Clinical Trials Report

Paclitaxel, carboplatin, and trastuzumab in HER2-positive metastatic breast cancer

Andrew D. Seidman, Larry Norton

Sentinel lymph node mapping for primary breast cancer

Lori L. Wilson, Armando E. Giuliano

Adjuvant chemotherapy for primary breast cancer

Monica Fornier, Clifford Hudis

Gene expression profiling of primary breast cancer

Roman Rouzier, Peter Wagner, Paolo Morandi, Lajos Pusztai

Leukemia and the nervous system

Marc C. Chamberlain

Management of primary intraocular lymphoma

Stella K. Kim, Chi-Chao Chan, Dana J. Wallace

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine